Pharma Focus Asia

TFF Pharmaceuticals Plans to Expand R&D Operations Facility in Texas, USA

Introduction:
TFF Pharmaceuticals, Inc plans to expand its R & D opeartions with the opening of new Austin facility located in Texas, USA.

Features:

The new research and development facility constructed with an area covering 3,500 square feet will increase the total lab space. The new lab designed with Thin Film Freezing (TFF) technology will be completely dedicated for the manufacturing of products and thus complementing the company’s current formulation development capabilities.

The facility remains as a central hub for research operations. The product development team will also be expanded at the new facility to meet the growing number of partnered projects.

The construction of the new R & D facility is laid to meet the raising demand of thin film freezing technology and product development services. Moreover, the facility allows to boost the testing capabilities to enable larger number of feasibility studies, including a focus on biologics and also meets the growing demand for thin film freezing-based products.

Specifications:

NameTFF Pharmaceuticals, Inc
TypeNew Construction
magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 20244th Annual Cleaning Validation 20242nd Annual Pharma Impurity Conclave 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Thermo Fisher - Drug Discovery and the impact of mAbsAdvanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference